biguanides has been researched along with Uremia in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Previato, G | 1 |
| Barbui, T | 1 |
| Guarnieri, GF | 1 |
| Palmari, V | 1 |
| Di Luzio, V | 1 |
| Campanacci, L | 1 |
1 other study available for biguanides and Uremia
| Article | Year |
|---|---|
[Effect of the administration of phenyl-ethyl-biguanide on tolerance to oral administration of glucose in chronic uremia].
Topics: Biguanides; Chronic Disease; Glucose; Glucose Tolerance Test; Humans; Insulin; Phenformin; Uremia | 1969 |